The Moore Criteria: Applicability in a diverse, non-trial, recurrent cervical cancer population.

Scott E Jordan,Matthew Schlumbrecht,Sophia George,J Matthew Pearson,Aaron Wolfson,Brian Slomovitz,Lorraine Portelance,Marilyn Huang

Gynecologic Oncology（2020）

引用 4|浏览43

暂无评分

摘要

•The Moore Criteria predict PFS, OS, and RR in recurrent cervical cancer patients outside of clinical trial populations.•The Moore Criteria predict PFS and OS in patients who received treatments other than systemic chemotherapy.•Removing Black race from the criteria did not change the prognostic value of the remaining four factors.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要